1e
19
1
49
2
2
18
1b
1d
18
31
25
28
1d
2 29
1d
25
Lisa B. Zaoutis, MD
88
25
28
82
3
4
1
b
Attending Physician, General Pediatrics, The Department of Pediatrics, CHOP
88
Administrative: Integrated Care Services, The Children's Hospital of Philadelphia
a0
Administrative: Co-develop unit-base Nurse Practitioner Programs, The Children's Hospital of Philadelphia
88
Administrative: Medical Hospitalist Team, The Children's Hospital of Philadelphia
78
Supervise: Sedation Unit, The Children's Hospital of Philadelphia
89
Develop: General Pediatrics Overflow Team, The Children's Hospital of Philadelphia
b4
General Pediatric Consult Services to Physical Medicine and Rehab inpatient services, The Children's Hospital of Philadelphia
86
Director, Pediatrics Residency Program, The Children's Hospital of Philadelphia
11
1d
46
Contact information
51
4
3
3
3
2
4
b
1f
51
Children's Hospital of Philadelphia
24 Pediatric Residency Program
45 3401 Civic Center Blvd., 9th Floor
Philadelphia, PA 19104
26
24 Pediatric Residency Program
45 3401 Civic Center Blvd., 9th Floor
Philadelphia, PA 19104
2e
Office: 215-590-1699
3d Fax: Zaoutis1@email.chop.edu
24
f
3d Fax: Zaoutis1@email.chop.edu
24
13
Education:
21 7 BS 14 (Biology) c
39 Rensselaer Polytechnic Institute, 1981.
21 7 MD c
2f Albany Medical College, 1983.
c
3
3
3
3
8b
Permanent link21 7 BS 14 (Biology) c
39 Rensselaer Polytechnic Institute, 1981.
21 7 MD c
2f Albany Medical College, 1983.
c
2 29
21
1e
1d
24
5e
8
8
8e “Controlled Comparison of RD Heparin versus Unfractionated Heparin for the Initial Treatment of Deep Vein Thrombosis.” 1990-1992.
8
c6 “Comparison of the Safety and Efficacy of RD Heparin versus Placebo for Prevention of Coronary Artery Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA).” 1990-1992.
8
d3 “Comparison of the Safety and Efficacy of RD Heparin versus Warfarin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-92.
8
d3 “Comparison of the Safety and Efficacy of RD Heparin versus Aspirin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-1992.
9
d6 “Comparison of the Safety and Efficacy of RD Heparin versus Unfractionated Heparin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Abdominal or Pelvic Surgery for Cancer.” 1989-1992.
8
7c “A Pharmacokinetic and Safety Study of Intravenous RD Heparin in Patients with Deep Vein Thrombosis.” 1989-1991.
26 7 1d 1f
27
Description of Research Expertise
a4 Site Principal Investigator for MARC-30 EMNet Study: Prospective Multicenter Study of Bronchiolitis Admissions: Etiology and Disposition. 2007-20118
8
8e “Controlled Comparison of RD Heparin versus Unfractionated Heparin for the Initial Treatment of Deep Vein Thrombosis.” 1990-1992.
8
c6 “Comparison of the Safety and Efficacy of RD Heparin versus Placebo for Prevention of Coronary Artery Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA).” 1990-1992.
8
d3 “Comparison of the Safety and Efficacy of RD Heparin versus Warfarin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-92.
8
d3 “Comparison of the Safety and Efficacy of RD Heparin versus Aspirin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-1992.
9
d6 “Comparison of the Safety and Efficacy of RD Heparin versus Unfractionated Heparin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Abdominal or Pelvic Surgery for Cancer.” 1989-1992.
8
7c “A Pharmacokinetic and Safety Study of Intravenous RD Heparin in Patients with Deep Vein Thrombosis.” 1989-1991.
26 7 1d 1f